George Morriss - Neuberger Berman Independent Fund Director
NBXG Stock | USD 13.43 0.19 1.40% |
Insider
George Morriss is Independent Fund Director of Neuberger Berman Next since 2021.
Age | 47 |
Tenure | 4 years |
Phone | 800 223 6448 |
George Morriss Latest Insider Activity
Tracking and analyzing the buying and selling activities of George Morriss against Neuberger Berman stock is an integral part of due diligence when investing in Neuberger Berman. George Morriss insider activity provides valuable insight into whether Neuberger Berman is net buyers or sellers over its current business cycle. Note, Neuberger Berman insiders must abide by specific rules, including filing SEC forms every time they buy or sell Neuberger Berman'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
George Morriss over three months ago Disposition of tradable shares by George Morriss of Neuberger Berman subject to Rule 16b-3 |
Similar Executives
Showing other executives | INSIDER Age | ||
Julia Short | Allianzgi Diversified Income | 48 | |
Richard Cavanagh | Blackrock Innovation Growth | 75 | |
Cynthia Egan | BlackRock Health Sciences | 66 | |
W Kester | Blackrock Innovation Growth | 70 | |
Jay Fife | Blackrock Innovation Growth | 51 | |
Erick Holt | Allianzgi Diversified Income | 67 | |
Charles Park | Blackrock Innovation Growth | 54 | |
Karen Robards | Blackrock Innovation Growth | 71 | |
Sarah Cogan | Allianzgi Diversified Income | 65 | |
Craig Ruckman | Allianzgi Diversified Income | 43 | |
J Holloman | BlackRock Health Sciences | 66 | |
Winnie Han | Doubleline Income Solutions | 33 | |
Catherine Lynch | BlackRock Health Sciences | 60 | |
F Drummond | Allianzgi Diversified Income | 58 | |
George Aylward | Allianzgi Diversified Income | 56 | |
Theodore Uhl | SRH Total Return | 46 | |
Brendon CFA | SRH Total Return | N/A | |
Jennifer Fromm | Allianzgi Diversified Income | 47 | |
Cynthia Egan | Blackrock Innovation Growth | 66 | |
Nancy Engberg | Allianzgi Diversified Income | 64 | |
Xiang Liu | BlackRock Health Sciences | N/A |
Neuberger Berman Next Leadership Team
Elected by the shareholders, the Neuberger Berman's board of directors comprises two types of representatives: Neuberger Berman inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Neuberger. The board's role is to monitor Neuberger Berman's management team and ensure that shareholders' interests are well served. Neuberger Berman's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Neuberger Berman's outside directors are responsible for providing unbiased perspectives on the board's policies.
Anthony Bernardo, Assistant Treasurer | ||
Anthony Maltese, Vice President | ||
Deborah Mclean, Director | ||
Tom Seip, Independent Fund Chairman of the Board | ||
Martha Goss, Independent Fund Director | ||
George Morriss, Independent Fund Director | ||
Agnes Diaz, Vice President | ||
James Stavridis, Independent Fund Director | ||
Claudia Brandon, Executive Vice President | ||
Josephine Marone, Assistant Secretary | ||
Peter Trapp, Independent Fund Director | ||
Joseph Amato, President, Chief Executive Officer, Fund Director | ||
Sheila James, Assistant Secretary | ||
Corey Issing, Chief Legal Officer | ||
Candace Straight, Independent Fund Director | ||
Michael Cosgrove, Independent Fund Director | ||
Michael Knetter, Independent Fund Director | ||
John Mcgovern, Treasurer and Principal Financial and Accounting Officer | ||
Owen Mcentee, Vice President | ||
Brian Kerrane, Chief Operating Officer | ||
Frank Rosato, Assistant Treasurer | ||
Marc Gary, Independent Fund Director | ||
Savonne Ferguson, Chief Compliance Officer |
Neuberger Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Neuberger Berman a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Shares Outstanding | 78.76 M | ||||
Shares Owned By Insiders | 0.07 % | ||||
Shares Owned By Institutions | 33.93 % | ||||
Number Of Shares Shorted | 33.08 K | ||||
Price To Book | 0.93 X | ||||
Price To Sales | 3.51 X | ||||
Total Debt | 6.67 M | ||||
Short Ratio | 0.15 X | ||||
Earnings Per Share | 3.77 X | ||||
Number Of Employees | 23 |
Currently Active Assets on Macroaxis
When determining whether Neuberger Berman Next is a strong investment it is important to analyze Neuberger Berman's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuberger Berman's future performance. For an informed investment choice regarding Neuberger Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuberger Berman Next. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuberger Berman. If investors know Neuberger will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuberger Berman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Neuberger Berman Next is measured differently than its book value, which is the value of Neuberger that is recorded on the company's balance sheet. Investors also form their own opinion of Neuberger Berman's value that differs from its market value or its book value, called intrinsic value, which is Neuberger Berman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuberger Berman's market value can be influenced by many factors that don't directly affect Neuberger Berman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuberger Berman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuberger Berman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuberger Berman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.